Member of Farmavita.Net offers transfer of marketing authorization for Ondansetron. Readily available is Ondansetron, 4-8 , tablets and injections, bulk supply with license for use of EU CTD Dossier.
Marketing authorization is obtained in EU in Reference Member State.
Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.
|Pharma licensing||Out-licensing (offer)|